News Headlines Article

Counterfeit drugs show need for tracking
San Francisco Chronicle

The discovery of a second batch of a phony cancer drug in the United States this week has frustrated regulators in California, where the nation’s most stringent law to track and trace pharmaceuticals was passed in 2004 but has yet to be implemented. Federal authorities said Tuesday that a counterfeit version of Genentech’s best-selling cancer drug Avastin has been found in undisclosed locations – less than two months after another bogus version of the same drug made it to medical offices in Southern California, Texas and Illinois.